Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT03357952

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • Algemeen Ziekenhuis Klina Brasschaat, Belgium
  • AZ St.-Jan Brugge-Oostende AV Bruges, Belgium
  • UZBrussel Brussels, Belgium
View all 13 locations
View Trial Details
Completed

A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation

NCT02918331

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hiroshima, Japan
  • Kanazawa, Japan
  • Nagoya, Japan
  • Osaka, Japan
View Trial Details
Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

NCT03768960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Avron Hospitals Pvt. Ltd Ahmedabad, India
  • M S Ramaiah Medical College and Hospital Bengaluru, India
  • Apollo Hospitals Bhubaneswar, India
  • Sparsh Hospitals & Critical Care (Pvt) Ltd Bhubaneswar, India
View all 16 locations
View Trial Details
Completed

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

NCT03870633

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 116 locations
View Trial Details
Completed

Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients

NCT02990338

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • BRCR Medical Center Inc. Site Number : 8400002 Plantation, Florida, United States
  • Dana Farber Site Number : 8400006 Boston, Massachusetts, United States
  • Investigational Site Number : 0360004 St Leonards, New South Wales, Australia
  • Investigational Site Number : 0360001 Waratah, New South Wales, Australia
View all 111 locations
View Trial Details

Related conditions